ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Silexion Therapeutics Corp
1.34
+0.0700
5.51%
成交量：
21.68萬
成交額：
28.41萬
市值：
446.33萬
市盈率：
-0.15
高：
1.36
開：
1.26
低：
1.07
收：
1.27
52周最高：
22.36
52周最低：
1.07
股本：
333.08萬
流通股本：
299.54萬
量比：
6.42
換手率：
7.24%
股息：
- -
股息率：
- -
每股收益(TTM):
-8.9597
每股收益(LYR):
-395.3595
淨資產收益率：
-771.23%
總資產收益率：
-144.27%
市淨率：
1.71
市盈率(LYR):
0.00
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Silexion Therapeutics Corp
交易所：
NASDAQ
成立時間：
2008
員工人數：
13
公司地址：
The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel
官網：
http://www.silexion.com
郵編：
9112001
電話：
972 2 674 3430
傳真：
972 2 643 0982
簡介：
Silexion Therapeutics Corp是一家開曼群島豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家臨床階段、專註於腫瘤學的生物技術公司，致力於發現和開發KRAS驅動的癌症的專有療法。Silexion的主要候選產品SIL-204B由局部給藥的小干擾RNA或siRNA組成，採用緩釋製劑，作為局部晚期胰腺癌患者的一線治療，與標準護理化療相結合。SIL-204B是繼Silexion的第一代siRNA候選產品SIG12D-LODER（也稱為Loder）的1期和2期臨床試驗之後的第二代siRNA候選產品。儘管未確定最大耐受劑量，但1期臨床試驗同時達到了主要和次要終點。在2期臨床試驗中，雖然沒有達到所有患者的主要終點，但結果显示KRAS G12D/V突變患者的治療組之間存在差異趨勢，Loder組的總體生存期優勢為9.3個月。關於2期臨床試驗中的次要安全性終點，達到了終點。對於次要療效終點，未觀察到統計學上的顯著差異，也沒有足夠的數據進行評估。由於1期和2期試驗的規模較小，它們沒有提供統計學意義。
董事
名稱
職位
Ilan Hadar
Chairman and Chief Executive Officer and Director
Amnon Peled
Director
Avner Lushi
Director
Dror J. Abramov
Director
Ilan Levin
Director
Ruth Alon
Director
Shlomo Noy
Director
股東
名稱
職位
Ilan Hadar
Chairman and Chief Executive Officer and Director
Mirit Horenshtein Hadar
Chief Financial Officer and Secretary
Mitchell Shirvan
Chief Scientific and Development Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SLXN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SLXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":1.34,"timestamp":1774382400000,"preClose":1.27,"halted":0,"volume":216818,"delay":0,"changeRate":0.05511811023622052,"floatShares":2995400,"shares":3330800,"eps":-8.959658,"marketStatus":"盤前交易","change":0.07,"latestTime":"03-25 05:35:10 EDT","open":1.26,"high":1.355,"low":1.07,"amount":284096.842218,"amplitude":0.224409,"askPrice":1.49,"askSize":100,"bidPrice":1.01,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-8.959658,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774445400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.34,"postHourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.34,"latestTime":"19:17 EDT","volume":165,"amount":220.87,"timestamp":1774394242504,"change":-0.02,"changeRate":-0.014925,"amplitude":0.014925},"volumeRatio":6.4162903445262724},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","floatShares":2995400,"roa":"-144.27%","roe":"-771.23%","lyrEps":-395.359461,"volumeRatio":6.4162903445262724,"shares":3330800,"dividePrice":0,"high":1.355,"amplitude":0.224409,"preClose":1.27,"low":1.07,"week52Low":1.07,"pbRate":"1.71","week52High":22.36,"institutionHeld":0,"latestPrice":1.34,"committee":0.333333,"eps":-8.959658,"divideRate":0,"volume":216818,"delay":0,"ttmEps":-8.959658,"open":1.26,"prevYearClose":1.92,"prevWeekClose":1.22,"prevMonthClose":1.725,"prevQuarterClose":1.92,"fiveDayClose":1.56,"twentyDayClose":1.5,"sixtyDayClose":2.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-29","symbol":"SLXN","defaultRemindTime":1753795800000,"type":"split","dateTimestamp":1753761600000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2024-11-29","symbol":"SLXN","defaultRemindTime":1732890600000,"type":"split","dateTimestamp":1732856400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-08-13","symbol":"SLXN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLXN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1765857600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SLXN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SLXN","date":"2026-03-23","current":-0.149559,"percent":0.623894,"low":-1.070842,"twenty":-0.587662,"median":-0.432424,"eighty":-0.128686,"high":-0.075397,"avg":-0.418218,"sd":0.242466,"marketCap":3814503},"quantilePoints":[{"date":"2025-05-02","current":-0.511745,"twenty":-0.505522,"median":-0.478123,"eighty":-0.462658,"marketCap":8414615},{"date":"2025-05-09","current":-0.508623,"twenty":-0.511745,"median":-0.504017,"eighty":-0.475134,"marketCap":8363285},{"date":"2025-05-16","current":-0.49368,"twenty":-0.511295,"median":-0.503966,"eighty":-0.488849,"marketCap":8117579},{"date":"2025-05-23","current":-0.504427,"twenty":-0.509135,"median":-0.49826,"eighty":-0.470682,"marketCap":8294286},{"date":"2025-05-30","current":-0.491275,"twenty":-0.511407,"median":-0.49826,"eighty":-0.475032,"marketCap":8078030},{"date":"2025-06-06","current":-0.471573,"twenty":-0.511407,"median":-0.49368,"eighty":-0.475196,"marketCap":7754067},{"date":"2025-06-13","current":-0.453201,"twenty":-0.509647,"median":-0.491403,"eighty":-0.471409,"marketCap":7451983},{"date":"2025-06-20","current":-0.41963,"twenty":-0.506945,"median":-0.488844,"eighty":-0.464552,"marketCap":6899984},{"date":"2025-06-27","current":-0.415025,"twenty":-0.504283,"median":-0.484008,"eighty":-0.449824,"marketCap":6824252},{"date":"2025-07-03","current":-0.415025,"twenty":-0.504048,"median":-0.478123,"eighty":-0.41963,"marketCap":6824252},{"date":"2025-07-11","current":-0.42265,"twenty":-0.503966,"median":-0.474592,"eighty":-0.417174,"marketCap":6949630},{"date":"2025-07-18","current":-0.440049,"twenty":-0.503178,"median":-0.468758,"eighty":-0.415025,"marketCap":7235727},{"date":"2025-07-25","current":-0.430889,"twenty":-0.49932,"median":-0.464408,"eighty":-0.415332,"marketCap":7085105},{"date":"2025-08-01","current":-0.509697,"twenty":-0.49932,"median":-0.462719,"eighty":-0.415332,"marketCap":8380951},{"date":"2025-08-08","current":-0.292718,"twenty":-0.495931,"median":-0.452101,"eighty":-0.414513,"marketCap":4813156},{"date":"2025-08-15","current":-0.251096,"twenty":-0.493608,"median":-0.447572,"eighty":-0.409037,"marketCap":4128768},{"date":"2025-08-22","current":-0.231991,"twenty":-0.492964,"median":-0.436237,"eighty":-0.386752,"marketCap":3814623},{"date":"2025-08-29","current":-0.263889,"twenty":-0.49148,"median":-0.430786,"eighty":-0.303498,"marketCap":4339133},{"date":"2025-09-05","current":-0.238814,"twenty":-0.491275,"median":-0.423383,"eighty":-0.280777,"marketCap":3926818},{"date":"2025-09-12","current":-0.168193,"twenty":-0.491275,"median":-0.420859,"eighty":-0.25246,"marketCap":2765601},{"date":"2025-09-19","current":-0.12316,"twenty":-0.486413,"median":-0.417583,"eighty":-0.247343,"marketCap":2025116},{"date":"2025-09-26","current":-0.128618,"twenty":-0.486106,"median":-0.415793,"eighty":-0.244955,"marketCap":2114871},{"date":"2025-10-03","current":-0.128618,"twenty":-0.484008,"median":-0.415025,"eighty":-0.242737,"marketCap":2114871},{"date":"2025-10-10","current":-0.136465,"twenty":-0.48104,"median":-0.413413,"eighty":-0.231991,"marketCap":2243896},{"date":"2025-10-17","current":-0.121454,"twenty":-0.478123,"median":-0.409651,"eighty":-0.138853,"marketCap":1997067},{"date":"2025-10-24","current":-0.114972,"twenty":-0.478123,"median":-0.401489,"eighty":-0.132201,"marketCap":1890482},{"date":"2025-10-31","current":-0.112584,"twenty":-0.477611,"median":-0.386196,"eighty":-0.129301,"marketCap":1851214},{"date":"2025-11-07","current":-0.097914,"twenty":-0.471573,"median":-0.312505,"eighty":-0.127936,"marketCap":1609995},{"date":"2025-11-14","current":-0.097914,"twenty":-0.471163,"median":-0.292718,"eighty":-0.123842,"marketCap":1609995},{"date":"2025-11-21","current":-0.080173,"twenty":-0.468758,"median":-0.272333,"eighty":-0.121795,"marketCap":1318288},{"date":"2025-11-28","current":-0.096549,"twenty":-0.467039,"median":-0.257237,"eighty":-0.120362,"marketCap":1587556},{"date":"2025-12-05","current":-1.070842,"twenty":-0.471245,"median":-0.259284,"eighty":-0.119953,"marketCap":9902075},{"date":"2025-12-12","current":-1.0279,"twenty":-0.478706,"median":-0.282158,"eighty":-0.120362,"marketCap":9504991},{"date":"2025-12-19","current":-0.821644,"twenty":-0.486167,"median":-0.30227,"eighty":-0.120704,"marketCap":7597740},{"date":"2025-12-26","current":-0.797975,"twenty":-0.491377,"median":-0.316599,"eighty":-0.121181,"marketCap":7378875},{"date":"2026-01-02","current":-0.6492,"twenty":-0.495368,"median":-0.386196,"eighty":-0.12159,"marketCap":6003152},{"date":"2026-01-09","current":-0.710063,"twenty":-0.504027,"median":-0.401489,"eighty":-0.122205,"marketCap":6565948},{"date":"2026-01-16","current":-0.825025,"twenty":-0.510588,"median":-0.409651,"eighty":-0.122955,"marketCap":7629006},{"date":"2026-01-23","current":-0.726969,"twenty":-0.515839,"median":-0.412313,"eighty":-0.12316,"marketCap":6722280},{"date":"2026-01-30","current":-0.662725,"twenty":-0.574408,"median":-0.414769,"eighty":-0.123296,"marketCap":6128218},{"date":"2026-02-06","current":-0.510569,"twenty":-0.606596,"median":-0.415025,"eighty":-0.12391,"marketCap":4721229},{"date":"2026-02-13","current":-0.534237,"twenty":-0.597129,"median":-0.417327,"eighty":-0.124456,"marketCap":4940094},{"date":"2026-02-20","current":-0.534237,"twenty":-0.591719,"median":-0.41963,"eighty":-0.125548,"marketCap":4940094},{"date":"2026-02-27","current":-0.588338,"twenty":-0.588338,"median":-0.42265,"eighty":-0.127254,"marketCap":5440357},{"date":"2026-03-06","current":-0.557906,"twenty":-0.584956,"median":-0.42723,"eighty":-0.127936,"marketCap":5158959},{"date":"2026-03-13","current":-0.563418,"twenty":-0.591719,"median":-0.432424,"eighty":-0.128618,"marketCap":5209923},{"date":"2026-03-20","current":-0.377654,"twenty":-0.588338,"median":-0.436237,"eighty":-0.128618,"marketCap":4498612},{"date":"2026-03-23","current":-0.320224,"twenty":-0.587662,"median":-0.432424,"eighty":-0.128686,"marketCap":3814503}],"updateTime":1774393809623},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134350646,"yearFounded":2008,"employeeNum":13,"address":"The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel","zipCode":"9112001","officePhone":"972 2 674 3430","officeFax":"972 2 643 0982"},"stockCompanyDetail":{"websiteUrl":"http://www.silexion.com","stockEarnings":[{"period":"1week","weight":-0.141},{"period":"1month","weight":-0.141},{"period":"3month","weight":-0.4322},{"period":"6month","weight":-0.6446},{"period":"1year","weight":-0.9202},{"period":"ytd","weight":-0.3021}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Silexion Therapeutics Corp是一家開曼群島豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家臨床階段、專註於腫瘤學的生物技術公司，致力於發現和開發KRAS驅動的癌症的專有療法。Silexion的主要候選產品SIL-204B由局部給藥的小干擾RNA或siRNA組成，採用緩釋製劑，作為局部晚期胰腺癌患者的一線治療，與標準護理化療相結合。SIL-204B是繼Silexion的第一代siRNA候選產品SIG12D-LODER（也稱為Loder）的1期和2期臨床試驗之後的第二代siRNA候選產品。儘管未確定最大耐受劑量，但1期臨床試驗同時達到了主要和次要終點。在2期臨床試驗中，雖然沒有達到所有患者的主要終點，但結果显示KRAS G12D/V突變患者的治療組之間存在差異趨勢，Loder組的總體生存期優勢為9.3個月。關於2期臨床試驗中的次要安全性終點，達到了終點。對於次要療效終點，未觀察到統計學上的顯著差異，也沒有足夠的數據進行評估。由於1期和2期試驗的規模較小，它們沒有提供統計學意義。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.016335},{"month":2,"riseRate":0.6,"avgChangeRate":-0.095221},{"month":3,"riseRate":0.8,"avgChangeRate":-0.033684},{"month":4,"riseRate":0.75,"avgChangeRate":-0.019534},{"month":5,"riseRate":0.4,"avgChangeRate":0.010327},{"month":6,"riseRate":0.4,"avgChangeRate":-0.035519},{"month":7,"riseRate":1,"avgChangeRate":0.055675},{"month":8,"riseRate":0.4,"avgChangeRate":-0.277749},{"month":9,"riseRate":0.6,"avgChangeRate":-0.230878},{"month":10,"riseRate":0.4,"avgChangeRate":-0.091257},{"month":11,"riseRate":0.4,"avgChangeRate":-0.018649},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12005}],"exchange":"NASDAQ","name":"Silexion Therapeutics Corp","nameEN":"Silexion Therapeutics Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":{"directors":[{"name":"Ilan Hadar","position":"Chairman and Chief Executive Officer and Director"},{"name":"Amnon Peled","position":"Director"},{"name":"Avner Lushi","position":"Director"},{"name":"Dror J. Abramov","position":"Director"},{"name":"Ilan Levin","position":"Director"},{"name":"Ruth Alon","position":"Director"},{"name":"Shlomo Noy","position":"Director"}],"executives":[{"name":"Ilan Hadar","position":"Chairman and Chief Executive Officer and Director"},{"name":"Mirit Horenshtein Hadar","position":"Chief Financial Officer and Secretary"},{"name":"Mitchell Shirvan","position":"Chief Scientific and Development Officer"}]}}}